Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Fong

Showing results (111-120 of 198) with videos related to

Pageof 20
Sort By:
Cancer Immunology Research|December 20, 2019
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell ResponsesSamantha K Greaney, Alain P Algazi, Katy K Tsai, et al.
Journal of the National Cancer Institute|September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancerLawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Transplantation|October 28, 2010
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeAndrew M Posselt, Gregory L Szot, Lynda A Frassetto, et al.
Science Advances|October 8, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastasesBridget P Keenan, Guilin Qiao, Nicholas Kunda, et al.
Clinical Genitourinary Cancer|October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 StudyMina Lee, Haemin Hong, Won Kim, et al.
Cell Reports|June 14, 2018
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer ImmunityDavid Wang, Jason Quiros, Kelly Mahuron, et al.
Cancer Research Communications|January 5, 2024
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction CancerMaira Soto, Erin L Filbert, Hai Yang, et al.
Cell|January 24, 2017
Systemic Immunity Is Required for Effective Cancer ImmunotherapyMatthew H Spitzer, Yaron Carmi, Nathan E Reticker-Flynn, et al.
Molecular Imaging and Biology|August 20, 2020
An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET RadiotracersJunnian Wei, Yung-Hua Wang, Chia Yin Lee, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
Pageof 20

Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
Cancer Immunology Research|December 20, 2019
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell ResponsesSamantha K Greaney, Alain P Algazi, Katy K Tsai, et al.
Journal of the National Cancer Institute|September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancerLawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Transplantation|October 28, 2010
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeAndrew M Posselt, Gregory L Szot, Lynda A Frassetto, et al.
Science Advances|October 8, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastasesBridget P Keenan, Guilin Qiao, Nicholas Kunda, et al.
Clinical Genitourinary Cancer|October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 StudyMina Lee, Haemin Hong, Won Kim, et al.
Cell Reports|June 14, 2018
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer ImmunityDavid Wang, Jason Quiros, Kelly Mahuron, et al.
Cancer Research Communications|January 5, 2024
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction CancerMaira Soto, Erin L Filbert, Hai Yang, et al.
Cell|January 24, 2017
Systemic Immunity Is Required for Effective Cancer ImmunotherapyMatthew H Spitzer, Yaron Carmi, Nathan E Reticker-Flynn, et al.
Molecular Imaging and Biology|August 20, 2020
An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET RadiotracersJunnian Wei, Yung-Hua Wang, Chia Yin Lee, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
Pageof 20